Beijing Med-Pharm Files S1 Registration Statement

COVENTRY, CT, January 12, 2005 - Beijing Med-Pharm (BJGP.PK) today announced that it has filed a registration statement with the United States Securities and Exchange Commission registering for sale 8,695,652 shares of its common stock. All of the shares are being registered on behalf of certain selling stockholders that purchased their shares in a private placement in March 2004. Beijing Med-Pharm will not receive any of the proceeds from the sale of common stock by the selling stockholders.

A registration statement relating to these shares has been filed with the Securities and Exchange Commission but has not yet become effective. These shares may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

For further information please contact

Beijing Med-Pharm
Ben Austin
+1 (917) 686 3979

Amphion Innovations plc
Josh Berkman, Media Relations
+1 (646) 747 7158

About Beijing Med-Pharm
Beijing Med-Pharm helps U.S. and European pharmaceutical companies wishing to enter the Chinese market. Beijing Med-Pharm offers an array of services designed to establish a market for western pharmaceuticals and to fulfill that market through a comprehensive distribution plan. Beijing Med-Pharm is a US-managed and US-listed company, traded on the Pink Sheets as (BJGP.PK).

On the web:

About Amphion Innovations plc
Amphion Innovations plc recently listed on the AIM Exchange in London under the symbol AMP.L. Amphion's business is the formation, financing, management, and development of life science and technology companies, working in partnership with corporations, governments, universities, and entrepreneurs seeking to commercialize their intellectual property.

On the web: